Thymosin Alpha-1 isn’t new. It’s not being whispered about in underground forums or passed around in black-labelled bottles. In fact, this peptide has been used in clinical settings for more than three decades — particularly in countries like China — as a treatment for chronic viral infections and immune dysfunction.
But in recent years, it’s…
